Literature DB >> 10594000

A proven de novo germline mutation in HNPCC.

C Kraus1, S Kastl, K Günther, S Klessinger, W Hohenberger, W G Ballhausen.   

Abstract

Hereditary non-polyposis colon cancer (HNPCC) is a heterogeneous group of tumour predisposition syndromes caused by germline mutations in at least four different mismatch repair genes. HNPCC patients are prone to the development of carcinomas of the intestinal tract and other specific sites. Identification of presumptive HNPCC patients is primarily based on a positive family history of colorectal cancer in at least two generations. In the course of mutation screening of the MLH1 and MSH2 genes in patients manifesting a carcinoma of the HNPCC tumour spectrum before the age of 45 years, we identified a germline MSH2 344delA frameshift mutation in a male proband. This index patient, at the age of 25 years, initially developed a large rectal adenoma that was removed by polypectomy. Ten years later he was operated on for an invasive right sided colon carcinoma in the caecum (International Union Against Cancer (UICC) stage III). The mother and father, aged 61 and 66 years, respectively, were healthy and had no family history of colorectal cancer. Subsequent molecular analyses excluded the germinal MSH2 344delA alteration identified in their son and at the same time paternity was confirmed with a set of informative polymorphic markers. Thus, the genetic alteration identified in our patient definitely represented a de novo germline mutation in one of the major HNPCC genes. This case report of a patient with colorectal cancer at a relatively young age with no family history is intended to encourage mutation screening of the MSH2 and MLH1 genes in similar cases to find out whether this group of patients contains an increased proportion of de novo mutations in mismatch repair genes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10594000      PMCID: PMC1734271     

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  8 in total

1.  Determining the frequency of de novo germline mutations in DNA mismatch repair genes.

Authors:  Aung Ko Win; Mark A Jenkins; Daniel D Buchanan; Mark Clendenning; Joanne P Young; Graham G Giles; Jack Goldblatt; Barbara A Leggett; John L Hopper; Stephen N Thibodeau; Noralane M Lindor
Journal:  J Med Genet       Date:  2011-06-02       Impact factor: 6.318

Review 2.  Clinical description of the Lynch syndrome [hereditary nonpolyposis colorectal cancer (HNPCC)].

Authors:  H F A Vasen
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

3.  Genetic and clinical characterisation of familial adenomatous polyposis: a population based study.

Authors:  A-L Moisio; H Järvinen; P Peltomäki
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

4.  A de novo pathogenic variant in the MSH6 gene in a 52 years-old woman.

Authors:  Elise Pierre-Noël; Fabrice Airaud; Estelle Cauchin; Céline Garrec; Ingrid Ricordeau; Clémence Michon; Olivier Kerdraon; Stéphane Bezieau; Caroline Abadie
Journal:  Fam Cancer       Date:  2021-09-14       Impact factor: 2.446

5.  A de novo germline MLH1 mutation in a Lynch syndrome patient with discordant immunohistochemical and molecular biology test results.

Authors:  Fabrice Airaud; Sébastien Küry; Isabelle Valo; Ingrid Maury; Dominique Bonneau; Olivier Ingster; Stéphane Bezieau
Journal:  World J Gastroenterol       Date:  2012-10-21       Impact factor: 5.742

6.  First report of a de novo germline mutation in the MLH1 gene.

Authors:  Rein P Stulp; Yvonne J Vos; Bart Mol; Arend Karrenbeld; Monique de Raad; Huub J C van der Mijle; Rolf H Sijmons
Journal:  World J Gastroenterol       Date:  2006-02-07       Impact factor: 5.742

7.  Lynch syndrome-associated colorectal cancer in a 16-year-old girl due to a de novo MSH2 mutation.

Authors:  Kristin Zajo; Susan I Colace; Danielle Mouhlas; Steven H Erdman
Journal:  BMJ Case Rep       Date:  2020-07-01

Review 8.  Pediatric adenomatous polyposis syndromes: an update.

Authors:  Steven H Erdman
Journal:  Curr Gastroenterol Rep       Date:  2007-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.